Blood Biomarker Guideline Sets Accuracy Thresholds for Alzheimer's Workup
This Alzheimer's Association guideline gives pharmacists concrete sensitivity and specificity thresholds for judging whether a plasma Alzheimer's test is fit for triaging or confirmatory use in specialty memory care.
📅 Journal publication: Jul 2025·Last updated: Aug 13, 2026
blood-based biomarkersplasma p-tau217p-tau181amyloid-beta 42/40Alzheimer's diseaseclinical practice guidelineGRADEdiagnostic test accuracyamyloid PETcerebrospinal fluid biomarkersmemory disordersneuropharmacologyNeurology / Neuropharmacology
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, Okrahvi HR, Paczynski M, Schindler SE, Teunissen CE, Zetterberg H, Carrillo MC, Edelmayer RM, Mahinrad S, McAteer MB, Kahale LA, Pahlke S, Tampi MP
Citation:Palmqvist S, Whitson HE, Allen LA, et al. Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025;21(7):e70535. doi:10.1002/alz.70535